DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,047,412 | +99619.0% | 12,283 | -3.5% | 0.08% | +1.2% |
| Q2 2023 | $3,056 | -3.2% | 12,733 | +1.6% | 0.08% | +29.0% |
| Q1 2023 | $3,158 | -3.9% | 12,529 | +1.2% | 0.06% | -12.7% |
| Q4 2022 | $3,285 | -99.9% | 12,376 | -0.4% | 0.07% | -2.7% |
| Q3 2022 | $3,211,000 | -3.0% | 12,430 | -4.8% | 0.07% | +30.4% |
| Q2 2022 | $3,310,000 | -12.6% | 13,056 | +1.1% | 0.06% | -12.5% |
| Q1 2022 | $3,789,000 | -12.0% | 12,917 | -1.4% | 0.06% | -16.9% |
| Q4 2021 | $4,308,000 | -1.8% | 13,094 | -9.1% | 0.08% | +1.3% |
| Q3 2021 | $4,387,000 | +13.0% | 14,409 | -0.4% | 0.08% | +5.6% |
| Q2 2021 | $3,881,000 | +17.1% | 14,463 | -1.7% | 0.07% | +18.0% |
| Q1 2021 | $3,313,000 | -2.1% | 14,720 | -3.3% | 0.06% | +3.4% |
| Q4 2020 | $3,383,000 | -35.5% | 15,227 | -37.5% | 0.06% | -44.3% |
| Q3 2020 | $5,242,000 | +28.4% | 24,344 | +5.4% | 0.11% | -33.3% |
| Q2 2020 | $4,084,000 | +35.1% | 23,096 | +5.8% | 0.16% | -73.7% |
| Q1 2020 | $3,022,000 | -12.9% | 21,836 | -3.4% | 0.60% | +27.6% |
| Q4 2019 | $3,468,000 | -4.3% | 22,594 | -9.9% | 0.47% | -8.3% |
| Q3 2019 | $3,623,000 | -0.2% | 25,086 | -1.3% | 0.52% | -2.6% |
| Q2 2019 | $3,632,000 | +0.9% | 25,413 | -6.8% | 0.53% | -2.4% |
| Q1 2019 | $3,598,000 | +10.1% | 27,255 | -14.0% | 0.54% | +7.5% |
| Q4 2018 | $3,267,000 | -5.1% | 31,683 | 0.0% | 0.51% | +17.4% |
| Q3 2018 | $3,443,000 | +39.7% | 31,683 | +26.8% | 0.43% | +27.1% |
| Q2 2018 | $2,465,000 | +18.9% | 24,983 | +17.9% | 0.34% | +6.6% |
| Q1 2018 | $2,074,000 | -18.7% | 21,183 | -22.9% | 0.32% | -9.7% |
| Q4 2017 | $2,551,000 | -9.3% | 27,483 | -16.2% | 0.35% | -15.0% |
| Q3 2017 | $2,813,000 | +48.9% | 32,789 | +46.5% | 0.41% | +42.8% |
| Q2 2017 | $1,889,000 | -1.4% | 22,389 | 0.0% | 0.29% | -3.7% |
| Q1 2017 | $1,915,000 | +9.9% | 22,389 | 0.0% | 0.30% | +3.8% |
| Q4 2016 | $1,743,000 | +14.1% | 22,389 | +14.9% | 0.29% | +41.5% |
| Q3 2016 | $1,528,000 | -25.4% | 19,489 | -3.9% | 0.20% | -37.3% |
| Q2 2016 | $2,049,000 | -14.1% | 20,289 | -19.3% | 0.33% | -13.3% |
| Q1 2016 | $2,386,000 | +3.0% | 25,149 | +0.8% | 0.38% | +2.4% |
| Q4 2015 | $2,317,000 | +9.0% | 24,949 | 0.0% | 0.37% | +3.7% |
| Q3 2015 | $2,126,000 | -0.0% | 24,949 | +0.4% | 0.36% | +7.9% |
| Q2 2015 | $2,127,000 | +6.2% | 24,849 | +5.3% | 0.33% | +6.5% |
| Q1 2015 | $2,003,000 | +11.8% | 23,589 | +12.8% | 0.31% | +16.6% |
| Q4 2014 | $1,792,000 | +7.2% | 20,908 | -5.0% | 0.26% | +3.9% |
| Q3 2014 | $1,672,000 | +0.8% | 22,008 | +4.5% | 0.26% | -2.7% |
| Q2 2014 | $1,658,000 | +0.7% | 21,057 | -4.1% | 0.26% | -8.1% |
| Q1 2014 | $1,647,000 | +4.7% | 21,957 | +7.8% | 0.28% | +8.0% |
| Q4 2013 | $1,573,000 | -4.6% | 20,372 | -14.3% | 0.26% | -11.4% |
| Q3 2013 | $1,648,000 | -6.6% | 23,772 | -14.7% | 0.30% | -8.0% |
| Q2 2013 | $1,764,000 | – | 27,862 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |